2.64
전일 마감가:
$2.65
열려 있는:
$2.65
하루 거래량:
374.84K
Relative Volume:
0.46
시가총액:
$168.22M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-2.5827
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
-8.97%
1개월 성능:
-2.22%
6개월 성능:
-54.87%
1년 성능:
-68.00%
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts Inc
|
2.64 | 168.85M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Critical Analysis: Treace Medical Concepts (NASDAQ:TMCI) versus Adagio Medical (NASDAQ:ADGM) - Defense World
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside - DirectorsTalk Interviews
Downgrade Watch: Will Treace Medical Concepts Inc stock hit new highs in YEARJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Treace Medical Concepts’ preliminary revenue down 9% in Q4 2025 - Medical Buyer
Treace Medical Issues Preliminary Q4 Results, Highlights Growth - TipRanks
Treace Medical Concepts, Inc. Provides Preliminary Revenue for the Fourth Quarter of 2025 - marketscreener.com
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - The Globe and Mail
Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative
Published on: 2026-01-13 05:27:40 - Улправда
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
How Treace Medical Concepts Inc. stock compares to industry benchmarksAnalyst Downgrade & Advanced Technical Analysis Signals - Улправда
Will Treace Medical Concepts Inc. stock recover faster than market2025 Valuation Update & Growth Oriented Trade Recommendations - Улправда
Will Treace Medical Concepts Inc. stock return to pre crisis levels2025 Pullback Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Treace Medical Concepts Inc. stock outperform Nasdaq indexDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - The Manila Times
Dow Theory LettersTreace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - FinancialContent
Is Treace Medical Concepts Inc. stock oversold or undervaluedMarket Activity Report & Accurate Intraday Trade Tips - Улправда
How Treace Medical Concepts Inc. stock reacts to Fed rate cutsJuly 2025 Spike Watch & Precise Buy Zone Identification - Улправда
How Treace Medical Concepts Inc. stock benefits from tech adoptionJuly 2025 Update & Breakout Confirmation Alerts - Улправда
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts - Benzinga
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st
How Recent Guidance Shifts Are Rewriting The Story For Treace Medical Concepts (TMCI) - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during Fed tightening cycles2026 world cup usa national team round of 16 goalkeepers transition play odds analysis tactical review - Улправда
Treace Medical’s Earnings Call: Growth Amid Challenges - MSN
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Bunion-focused medtech CEO to speak at J.P. Morgan Healthcare Conference - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading Down 0.8%Time to Sell? - MarketBeat
Why hedge funds are buying Treace Medical Concepts Inc. stockWeekly Market Snapshot & Low Entry Cost Capital - bollywoodhelpline.com
Treace Medical’s Innovative Foot Correction Study: A Potential Game-Changer? - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
What valuation multiples suggest for Treace Medical Concepts Inc. stock2025 Retail Activity & Capital Efficiency Focused Ideas - Улправда
Treace Medical raises USD 175M in debt financing - Medical Buyer
Is Treace Medical Concepts Inc. stock a contrarian buy2025 Winners & Losers & Free High Return Stock Watch Alerts - Улправда
Is Treace Medical Concepts Inc. stock resilient to inflationWeekly Loss Report & Safe Entry Momentum Stock Tips - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - ACCESS Newswire
Treace Medical Concepts (TMCI) Analyst Rating Update: Truist Sec - GuruFocus
Treace Medical Concepts, Inc. Secures Up to $175 Million in Debt Financing - marketscreener.com
Truist Securities Trims Price Target on Treace Medical Concepts to $3 From $4, Maintains Hold Rating - marketscreener.com
Treace Medical secures up to $175 million in debt financing - marketscreener.com
Treace Medical Secures Up To $175 Million In Debt Financing - TradingView — Track All Markets
Treace Medical Completes New Secured Loan Financing Deal - TipRanks
Treace Medical Secures Up to $175 Million in Debt Financing - The Manila Times
Treace Medical Concepts Announces $175 Million Secured Loan Agreement to Enhance Financial Flexibility and Market Position - Quiver Quantitative
[8-K] TREACE MEDICAL CONCEPTS, INC. Reports Material Event | TMCI SEC FilingForm 8-K - Stock Titan
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):